English
简体中文
Total: £ 56.28
Published Date: 2025-03-25 | Pages: 74 | Tables: 76 | Medical Care
The global market for Macrophage Anticancer Therapy was valued at US$ 431 million in the year 2024 and is projected to reach a revised size of US$ 605 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Macrophage anticancer therapy is an immunotherapy that utilizes the anticancer activity of macrophages. Macrophages are important cells in the immune system with multiple functions, including phagocytosis, killing of pathogens and tumor cells, and regulation of immune responses. In macrophage anticancer therapy, macrophages are activated or modified to more effectively recognize and attack tumor cells. This therapy can be achieved through various routes, such as direct injection of activated macrophages into the tumor site or using gene engineering techniques to modify macrophages to have stronger anticancer abilities. Macrophage anticancer therapy provides new ideas and methods for tumor treatment and brings hope to cancer patients.
North American market for Macrophage Anticancer Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Macrophage Anticancer Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Macrophage Anticancer Therapy in Solid Tumors is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Macrophage Anticancer Therapy include Carisma, Myeloid Therapeutics, Inceptor Bio, Cell-Origin, Rocrock Bio, Shaanxi Jushi Kangji Biotechnology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Macrophage Anticancer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Macrophage Anticancer Therapy.
The Macrophage Anticancer Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Macrophage Anticancer Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Macrophage Anticancer Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Carisma
Myeloid Therapeutics
Inceptor Bio
Cell-Origin
Rocrock Bio
Shaanxi Jushi Kangji Biotechnology
Segment by Type
CD19
HER2
Others
Segment by Application
Solid Tumors
Non-Solid Tumors
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Macrophage Anticancer Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Macrophage Anticancer Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CD19
1.2.3 HER2
1.2.4 Others
1.3 Market by Application
1.3.1 Global Macrophage Anticancer Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Solid Tumors
1.3.3 Non-Solid Tumors
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Macrophage Anticancer Therapy Market Perspective (2020-2031)
2.2 Global Macrophage Anticancer Therapy Growth Trends by Region
2.2.1 Global Macrophage Anticancer Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Macrophage Anticancer Therapy Historic Market Size by Region (2020-2025)
2.2.3 Macrophage Anticancer Therapy Forecasted Market Size by Region (2026-2031)
2.3 Macrophage Anticancer Therapy Market Dynamics
2.3.1 Macrophage Anticancer Therapy Industry Trends
2.3.2 Macrophage Anticancer Therapy Market Drivers
2.3.3 Macrophage Anticancer Therapy Market Challenges
2.3.4 Macrophage Anticancer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Macrophage Anticancer Therapy Players by Revenue
3.1.1 Global Top Macrophage Anticancer Therapy Players by Revenue (2020-2025)
3.1.2 Global Macrophage Anticancer Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Top Macrophage Anticancer Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Macrophage Anticancer Therapy Revenue
3.4 Global Macrophage Anticancer Therapy Market Concentration Ratio
3.4.1 Global Macrophage Anticancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Macrophage Anticancer Therapy Revenue in 2024
3.5 Global Key Players of Macrophage Anticancer Therapy Head office and Area Served
3.6 Global Key Players of Macrophage Anticancer Therapy, Product and Application
3.7 Global Key Players of Macrophage Anticancer Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Macrophage Anticancer Therapy Breakdown Data by Type
4.1 Global Macrophage Anticancer Therapy Historic Market Size by Type (2020-2025)
4.2 Global Macrophage Anticancer Therapy Forecasted Market Size by Type (2026-2031)
5 Macrophage Anticancer Therapy Breakdown Data by Application
5.1 Global Macrophage Anticancer Therapy Historic Market Size by Application (2020-2025)
5.2 Global Macrophage Anticancer Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Macrophage Anticancer Therapy Market Size (2020-2031)
6.2 North America Macrophage Anticancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Macrophage Anticancer Therapy Market Size by Country (2020-2025)
6.4 North America Macrophage Anticancer Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Macrophage Anticancer Therapy Market Size (2020-2031)
7.2 Europe Macrophage Anticancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Macrophage Anticancer Therapy Market Size by Country (2020-2025)
7.4 Europe Macrophage Anticancer Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Macrophage Anticancer Therapy Market Size (2020-2031)
8.2 Asia-Pacific Macrophage Anticancer Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Macrophage Anticancer Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Macrophage Anticancer Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Macrophage Anticancer Therapy Market Size (2020-2031)
9.2 Latin America Macrophage Anticancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Macrophage Anticancer Therapy Market Size by Country (2020-2025)
9.4 Latin America Macrophage Anticancer Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Macrophage Anticancer Therapy Market Size (2020-2031)
10.2 Middle East & Africa Macrophage Anticancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Macrophage Anticancer Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Macrophage Anticancer Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Carisma
11.1.1 Carisma Company Details
11.1.2 Carisma Business Overview
11.1.3 Carisma Macrophage Anticancer Therapy Introduction
11.1.4 Carisma Revenue in Macrophage Anticancer Therapy Business (2020-2025)
11.1.5 Carisma Recent Development
11.2 Myeloid Therapeutics
11.2.1 Myeloid Therapeutics Company Details
11.2.2 Myeloid Therapeutics Business Overview
11.2.3 Myeloid Therapeutics Macrophage Anticancer Therapy Introduction
11.2.4 Myeloid Therapeutics Revenue in Macrophage Anticancer Therapy Business (2020-2025)
11.2.5 Myeloid Therapeutics Recent Development
11.3 Inceptor Bio
11.3.1 Inceptor Bio Company Details
11.3.2 Inceptor Bio Business Overview
11.3.3 Inceptor Bio Macrophage Anticancer Therapy Introduction
11.3.4 Inceptor Bio Revenue in Macrophage Anticancer Therapy Business (2020-2025)
11.3.5 Inceptor Bio Recent Development
11.4 Cell-Origin
11.4.1 Cell-Origin Company Details
11.4.2 Cell-Origin Business Overview
11.4.3 Cell-Origin Macrophage Anticancer Therapy Introduction
11.4.4 Cell-Origin Revenue in Macrophage Anticancer Therapy Business (2020-2025)
11.4.5 Cell-Origin Recent Development
11.5 Rocrock Bio
11.5.1 Rocrock Bio Company Details
11.5.2 Rocrock Bio Business Overview
11.5.3 Rocrock Bio Macrophage Anticancer Therapy Introduction
11.5.4 Rocrock Bio Revenue in Macrophage Anticancer Therapy Business (2020-2025)
11.5.5 Rocrock Bio Recent Development
11.6 Shaanxi Jushi Kangji Biotechnology
11.6.1 Shaanxi Jushi Kangji Biotechnology Company Details
11.6.2 Shaanxi Jushi Kangji Biotechnology Business Overview
11.6.3 Shaanxi Jushi Kangji Biotechnology Macrophage Anticancer Therapy Introduction
11.6.4 Shaanxi Jushi Kangji Biotechnology Revenue in Macrophage Anticancer Therapy Business (2020-2025)
11.6.5 Shaanxi Jushi Kangji Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Macrophage Anticancer Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of CD19
Table 3. Key Players of HER2
Table 4. Key Players of Others
Table 5. Global Macrophage Anticancer Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Macrophage Anticancer Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Macrophage Anticancer Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Macrophage Anticancer Therapy Market Share by Region (2020-2025)
Table 9. Global Macrophage Anticancer Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Macrophage Anticancer Therapy Market Share by Region (2026-2031)
Table 11. Macrophage Anticancer Therapy Market Trends
Table 12. Macrophage Anticancer Therapy Market Drivers
Table 13. Macrophage Anticancer Therapy Market Challenges
Table 14. Macrophage Anticancer Therapy Market Restraints
Table 15. Global Macrophage Anticancer Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Macrophage Anticancer Therapy Market Share by Players (2020-2025)
Table 17. Global Top Macrophage Anticancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macrophage Anticancer Therapy as of 2024)
Table 18. Ranking of Global Top Macrophage Anticancer Therapy Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Macrophage Anticancer Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Macrophage Anticancer Therapy, Headquarters and Area Served
Table 21. Global Key Players of Macrophage Anticancer Therapy, Product and Application
Table 22. Global Key Players of Macrophage Anticancer Therapy, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Macrophage Anticancer Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Macrophage Anticancer Therapy Revenue Market Share by Type (2020-2025)
Table 26. Global Macrophage Anticancer Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Macrophage Anticancer Therapy Revenue Market Share by Type (2026-2031)
Table 28. Global Macrophage Anticancer Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Macrophage Anticancer Therapy Revenue Market Share by Application (2020-2025)
Table 30. Global Macrophage Anticancer Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Macrophage Anticancer Therapy Revenue Market Share by Application (2026-2031)
Table 32. North America Macrophage Anticancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Macrophage Anticancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Macrophage Anticancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Macrophage Anticancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Macrophage Anticancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Macrophage Anticancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Macrophage Anticancer Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Macrophage Anticancer Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Macrophage Anticancer Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Macrophage Anticancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Macrophage Anticancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Macrophage Anticancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Macrophage Anticancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Macrophage Anticancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Macrophage Anticancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 47. Carisma Company Details
Table 48. Carisma Business Overview
Table 49. Carisma Macrophage Anticancer Therapy Product
Table 50. Carisma Revenue in Macrophage Anticancer Therapy Business (2020-2025) & (US$ Million)
Table 51. Carisma Recent Development
Table 52. Myeloid Therapeutics Company Details
Table 53. Myeloid Therapeutics Business Overview
Table 54. Myeloid Therapeutics Macrophage Anticancer Therapy Product
Table 55. Myeloid Therapeutics Revenue in Macrophage Anticancer Therapy Business (2020-2025) & (US$ Million)
Table 56. Myeloid Therapeutics Recent Development
Table 57. Inceptor Bio Company Details
Table 58. Inceptor Bio Business Overview
Table 59. Inceptor Bio Macrophage Anticancer Therapy Product
Table 60. Inceptor Bio Revenue in Macrophage Anticancer Therapy Business (2020-2025) & (US$ Million)
Table 61. Inceptor Bio Recent Development
Table 62. Cell-Origin Company Details
Table 63. Cell-Origin Business Overview
Table 64. Cell-Origin Macrophage Anticancer Therapy Product
Table 65. Cell-Origin Revenue in Macrophage Anticancer Therapy Business (2020-2025) & (US$ Million)
Table 66. Cell-Origin Recent Development
Table 67. Rocrock Bio Company Details
Table 68. Rocrock Bio Business Overview
Table 69. Rocrock Bio Macrophage Anticancer Therapy Product
Table 70. Rocrock Bio Revenue in Macrophage Anticancer Therapy Business (2020-2025) & (US$ Million)
Table 71. Rocrock Bio Recent Development
Table 72. Shaanxi Jushi Kangji Biotechnology Company Details
Table 73. Shaanxi Jushi Kangji Biotechnology Business Overview
Table 74. Shaanxi Jushi Kangji Biotechnology Macrophage Anticancer Therapy Product
Table 75. Shaanxi Jushi Kangji Biotechnology Revenue in Macrophage Anticancer Therapy Business (2020-2025) & (US$ Million)
Table 76. Shaanxi Jushi Kangji Biotechnology Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
Table 80. Authors List of This Report
List of Figures
Figure 1. Macrophage Anticancer Therapy Picture
Figure 2. Global Macrophage Anticancer Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Macrophage Anticancer Therapy Market Share by Type: 2024 VS 2031
Figure 4. CD19 Features
Figure 5. HER2 Features
Figure 6. Others Features
Figure 7. Global Macrophage Anticancer Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Macrophage Anticancer Therapy Market Share by Application: 2024 VS 2031
Figure 9. Solid Tumors Case Studies
Figure 10. Non-Solid Tumors Case Studies
Figure 11. Macrophage Anticancer Therapy Report Years Considered
Figure 12. Global Macrophage Anticancer Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Macrophage Anticancer Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Macrophage Anticancer Therapy Market Share by Region: 2024 VS 2031
Figure 15. Global Macrophage Anticancer Therapy Market Share by Players in 2024
Figure 16. Global Macrophage Anticancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Macrophage Anticancer Therapy Revenue in 2024
Figure 18. North America Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Macrophage Anticancer Therapy Market Share by Country (2020-2031)
Figure 20. United States Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Macrophage Anticancer Therapy Market Share by Country (2020-2031)
Figure 24. Germany Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Macrophage Anticancer Therapy Market Share by Region (2020-2031)
Figure 32. China Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Macrophage Anticancer Therapy Market Share by Country (2020-2031)
Figure 40. Mexico Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Macrophage Anticancer Therapy Market Share by Country (2020-2031)
Figure 44. Turkey Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Macrophage Anticancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Carisma Revenue Growth Rate in Macrophage Anticancer Therapy Business (2020-2025)
Figure 48. Myeloid Therapeutics Revenue Growth Rate in Macrophage Anticancer Therapy Business (2020-2025)
Figure 49. Inceptor Bio Revenue Growth Rate in Macrophage Anticancer Therapy Business (2020-2025)
Figure 50. Cell-Origin Revenue Growth Rate in Macrophage Anticancer Therapy Business (2020-2025)
Figure 51. Rocrock Bio Revenue Growth Rate in Macrophage Anticancer Therapy Business (2020-2025)
Figure 52. Shaanxi Jushi Kangji Biotechnology Revenue Growth Rate in Macrophage Anticancer Therapy Business (2020-2025)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
